US Stocks
Vaccitech plc - ADR
Vaccitech plc - ADR

Vaccitech plc - ADR








Key Stats

Today Low/High
14.55 / 14.66
52 Week Low/High
$12.25 / $17.99
Market Cap

Company Details

Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company’s proprietary platform comprises proprietary modified simian adenoviral vectors, known as ChAdOx1 and ChAdOx2, as well as the well-validated Modified Vaccinia Ankara, or MVA, boost vector, both with demonstrable tolerability profiles and without the ability to replicate in humans. The combination of a ChAdOx prime treatment with subsequent MVA boost has consistently generated significantly higher magnitudes of CD8+ T cells compared with other technologies and approaches. The company has a broad pipeline of both clinical and preclinical stage therapeutic programs in solid tumors and viral infections and prophylactic viral vaccine programs. Vaccitech co-invented a COVID-19 vaccine with the University of Oxford, now approved for use in many territories and exclusively licensed worldwide to AstraZeneca through Oxford University Innovation, or OUI. Vaccitech is entitled to receive a share of the milestones and royalty income received by OUI from AstraZeneca.
Vaccitech plc - ADR

Discover more

Frequently Asked Questions

What is Vaccitech plc - ADR share price today

Can Indians buy Vaccitech plc - ADR shares?

How can I buy Vaccitech plc - ADR shares from India?

Can Fractional shares of Vaccitech plc - ADR be purchased?

What are the documents required to start investing in Vaccitech plc - ADR stocks?

We are a SEBI registered investement advisor